A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT02925117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Multicenter, Randomized, Placebo-Controlled, Double-Blind Dose-Ranging Study to Evaluate ABT-494 (Upadacitinib) in Adult Subjects With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study was to evaluate the safety and efficacy of multiple doses of upadacitinib monotherapy versus placebo in the treatment of adults with moderate to severe atopic dermatitis (AD).
Study identification
- NCT ID
- NCT02925117
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2016
- Primary completion
- Aug 9, 2017
- Completion
- Jan 30, 2019
- Last update posted
- Jul 15, 2020
2016 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ForCare Clinical Research /ID# 157974 | Tampa | Florida | 33613-1244 | — |
| Advanced Medical Research /ID# 154516 | Sandy Springs | Georgia | 30328-6141 | — |
| DermAssociates /ID# 153584 | Rockville | Maryland | 20850 | — |
| Tufts Medical Center /ID# 153586 | Boston | Massachusetts | 02111 | — |
| Psoriasis Treatment Ctr NJ /ID# 153578 | East Windsor | New Jersey | 08520 | — |
| Icahn School of Med Mt. Sinai /ID# 153582 | New York | New York | 10029 | — |
| Univ Rochester Med Ctr /ID# 154477 | Rochester | New York | 14642 | — |
| Arlington Research Center, Inc /ID# 154522 | Arlington | Texas | 76011 | — |
| Modern Research Associates, PL /ID# 154487 | Dallas | Texas | 75231 | — |
| Center for Clinical Studies /ID# 153589 | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02925117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02925117 live on ClinicalTrials.gov.